Table 3 Study measures
Construct | Measures | Data source | Timing of administration |
|---|---|---|---|
Pre-implementation phase | |||
 Intervention characteristics | • Organizational readiness to change (12-item Evidence Scale) | • Steering committee and staff surveys | Baseline |
 Inner setting | • Implementation Climate Scale • Implementation Leadership Scale • Organizational Culture domain of the Organizational Social Context Scale | • Semi-structured interviews with Key Stakeholders • Steering committee and staff surveys | Baseline |
 Implementation process | • External Change Agent Support tool (3-item tool) • Organizational Readiness to Change Assessment (Facilitation Scale-8 item) | • Steering committee and staff surveys | Baseline |
Implementation phase | |||
 Systolic BP reduction (primary outcome) | • Automated BP Monitor (according to WHO guidelines) • Participant characteristics | • Clinic patient medical records | Baseline and 12 months |
 Adoption of TASSH (secondary outcome) | • CVD Risk Assessment • Lifestyle Counseling • Medication Titration | • Nurse interviews and questionnaires • Attendance log sheet patient visits | 12 months |
Post-implementation phase | |||
 Sustainability of TASSH (secondary outcome) | • CVD Risk Assessment • Lifestyle Counseling • Medication Titration | • Nurse interviews and questionnaires • Attendance log sheet patient visits | 24 months |